SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-06-004963
Filing Date
2006-11-14
Accepted
2006-11-14 13:23:12
Documents
8
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q w26990e10vq.htm 10-Q 348610
2 EXHIBIT 10.1 w26990exv10w1.htm EX-10.1 8812
3 EXHIBIT 10.2 w26990exv10w2.htm EX-10.2 64328
4 EXHIBIT 10.3 w26990exv10w3.htm EX-10.3 17573
5 EXHIBIT 31.1 w26990exv31w1.htm EX-31.1 9093
6 EXHIBIT 31.2 w26990exv31w2.htm EX-31.2 9163
7 EXHIBIT 32.1 w26990exv32w1.htm EX-32.1 3761
8 EXHIBIT 32.2 w26990exv32w2.htm EX-32.2 3873
  Complete submission text file 0000950133-06-004963.txt   466589
Mailing Address 508 LAPP ROAD MALVERN PA 19355
Business Address 508 LAPP ROAD MALVERN PA 19355 4849131200
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 061213284
SIC: 2836 Biological Products, (No Diagnostic Substances)